Atlas Trials

A Single-dose, Dose-escalation Study of a Long-acting MOD-5014 in Healthy Adult Male

Clinical trial NCT02919800 · COMPLETED

Trial details

NCT number
NCT02919800
Sponsor
OPKO Health, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hemophilia A or B With Inhibitors
Start date
2017-01-22
Primary completion
2018-02-21
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.